Andrzej Lewenstam

Prof. Andrzej Lewenstam

Abo Akademi University
+1
orcid

Research Focus & Metrics

Academic Career Length

51Years (1976-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2000 in Clinica Chimica Acta
Verified
Journal Article
Closed access
NSNils-Erik L Saris
Nils-Erik L Saris
EMEero Mervaala
Eero Mervaala
HKHeikki Karppanen
Heikki Karppanen
JKJahangir A Khawaja
Jahangir A Khawaja
Andrzej LewenstamAndrzej Lewenstam
Andrzej Lewenstam

12 January 2008 in Chemical Reviews
Verified
Journal Article
Closed access
Johan BobackaJohan Bobacka
Johan Bobacka
AIAri Ivaska
Ari Ivaska
Andrzej LewenstamAndrzej Lewenstam
Andrzej Lewenstam

1 July 2000 in Journal of Electroanalytical Chemistry
Verified
Journal Article
Closed access
Johan BobackaJohan Bobacka
Johan Bobacka
Andrzej LewenstamAndrzej Lewenstam
Andrzej Lewenstam
AIAri Ivaska
Ari Ivaska

1 November 1992 in Analytical Chemistry
Verified
Journal Article
Closed access
ACAodhmar. Cadogan
Aodhmar. Cadogan
ZGZhiqiang. Gao
Zhiqiang. Gao
Andrzej LewenstamAndrzej Lewenstam
Andrzej Lewenstam
AIAri. Ivaska
Ari. Ivaska
Dermot DiamondDermot Diamond
Dermot Diamond

30 April 2003 in Electroanalysis
Verified
Journal Article
Open access
PDF file
Johan BobackaJohan Bobacka
Johan Bobacka
AIAri Ivaska
Ari Ivaska
Andrzej LewenstamAndrzej Lewenstam
Andrzej Lewenstam
Conducting polymers (electroactive conjugated polymers, ECPs) have emerged as one of the most promising transducers for chemical sensors. This is related to the unique electrical, electrochemical and optical properties of conjugated polymers that can be used to convert chemical information (concentration, activity, partial pressure) into electrical or optical signals in the solid state. Application of conjugated polymers in potentiometric ion sensors (ion‐selective electrodes, ISEs) is reviewed.

14 July 2005 in Clinical Chemistry
Verified
Journal Article
Closed access
PDF file
PDPaul D’orazio
Paul D’orazio
RBRobert W. Burnett
Robert W. Burnett
NFNiels Fogh-Andersen
Niels Fogh-Andersen
EJEllis Jacobs
Ellis Jacobs
KKKatsuhiko Kuwa
Katsuhiko Kuwa
AOAnthony O. Okorodudu
Anthony O. Okorodudu
In current clinical practice, plasma and blood glucose are used interchangeably with a consequent risk of clinical misinterpretation. In human blood, glucose, like water, is distributed between erythrocytes and plasma. The molality of glucose (amount of glucose per unit of water mass) is the same throughout the sample, but the concentration is higher in plasma because the concentration of water and, therefore, glucose is higher in plasma than in erythrocytes. Different devices for the measurement of glucose may detect and report fundamentally different quantities. Different water concentrations in calibrators, plasma, and erythrocyte fluid can explain some of the differences. Results of glucose measurements depend on sample type and on whether methods require sample dilution or use biosensors in undiluted samples. If the results are mixed up or used indiscriminately, the differences may exceed the maximum allowable error of glucose determinations for diagnosing and monitoring diabetes mellitus, and complicate the treatment. The goal of the IFCC Scientific Division Working Group on Selective Electrodes and Point of Care Testing (IFCC-SD, WG-SEPOCT) is to reach a global consensus on reporting results. The document recommends reporting the concentration of glucose in plasma (with the unit mmol/L), irrespective of sample type or measurement technique. A constant factor of 1.11 is used to convert concentration in whole blood to the equivalent concentration in the pertinent plasma. The conversion will provide harmonized results, facilitating the classification and care of patients and leading to fewer therapeutic misjudgments.